X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (227) 227
female (163) 163
male (158) 158
cardiac & cardiovascular systems (136) 136
middle aged (125) 125
aged (111) 111
index medicus (99) 99
adult (74) 74
cardiovascular (72) 72
treatment outcome (69) 69
follow-up studies (61) 61
aged, 80 and over (47) 47
time factors (46) 46
stents (44) 44
mortality (43) 43
analysis (37) 37
outcomes (37) 37
abridged index medicus (34) 34
cardiology (34) 34
risk factors (34) 34
heart attacks (33) 33
coronary angiography (31) 31
percutaneous coronary intervention (30) 30
prospective studies (30) 30
stent (30) 30
electrocardiography (29) 29
internal medicine (29) 29
italy (29) 29
prognosis (28) 28
implantation (27) 27
stenosis (26) 26
aortic valve stenosis - surgery (25) 25
drug-eluting stents (25) 25
adolescent (24) 24
cardiology and cardiovascular medicine (24) 24
replacement (24) 24
echocardiography (23) 23
pregnancy (23) 23
retrospective studies (23) 23
studies (23) 23
coronary artery disease (22) 22
thrombosis (22) 22
angioplasty (21) 21
myocardial infarction (21) 21
risk assessment (20) 20
care and treatment (19) 19
economics (19) 19
registries (19) 19
angioplasty, balloon, coronary (18) 18
impact (17) 17
management (17) 17
trial (17) 17
acute myocardial-infarction (16) 16
cardiovascular disease (16) 16
coronary artery disease - therapy (16) 16
coronary vessels (16) 16
developing countries (16) 16
heart valve diseases (16) 16
kaplan-meier estimate (16) 16
angioplasty, balloon, coronary - adverse effects (15) 15
heart valve prosthesis (15) 15
italy - epidemiology (15) 15
predictors (15) 15
angiography (14) 14
cardiac catheterization (14) 14
cardiac patients (14) 14
child (14) 14
disease (14) 14
intervention (14) 14
patients (14) 14
restenosis (14) 14
severity of illness index (14) 14
surgery (14) 14
aortic valve - surgery (13) 13
health aspects (13) 13
metaanalysis (13) 13
prosthesis design (13) 13
transcatheter aortic valve replacement (13) 13
age factors (12) 12
angioplasty, balloon, coronary - instrumentation (12) 12
coronary heart disease (12) 12
diabetes (12) 12
drug therapy (12) 12
heart valve prosthesis implantation - methods (12) 12
incidence (12) 12
medicine, general & internal (12) 12
myocardial infarction - etiology (12) 12
prevention (12) 12
risk (12) 12
sex factors (12) 12
stroke (12) 12
transluminal angioplasty (12) 12
aortic valve stenosis - mortality (11) 11
child, preschool (11) 11
lesions (11) 11
myocardial infarction - therapy (11) 11
radiography (11) 11
acute coronary syndromes (10) 10
aortic valve insufficiency - surgery (10) 10
arrhythmias, cardiac - etiology (10) 10
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Pontifical Inst. Mediaeval Studies - Library use only (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Robarts - Stacks (2) 2
UofT at Mississauga - Stacks (2) 2
Victoria University CRRS - Library use only (2) 2
Royal Ontario Museum - Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 25, pp. 2387 - 2397
In this trial, patients with an acute coronary syndrome within the previous 10 days were randomly assigned to simvastatin plus either ezetimibe or placebo. At... 
CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1317 - 1326
Saxagliptin, a new oral antihyperglycemic drug in the DPP-4 inhibitor class, had no effect on the risk of cardiovascular events in patients with type 2... 
ALL-CAUSE | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | EVENTS | GLUCOSE CONTROL | MICROALBUMINURIA | DISEASE | CLINICAL-USE | PREVENTION | RISK | DEATH | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Adamantane - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Hypoglycemia - chemically induced | Heart Failure - epidemiology | Diabetes Mellitus, Type 2 - complications | Adamantane - adverse effects | Adamantane - analogs & derivatives | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Dipeptides - therapeutic use | Double-Blind Method | Pancreatitis - epidemiology | Dipeptides - adverse effects | Kaplan-Meier Estimate | Pancreatitis - chemically induced | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Patient outcomes | Dosage and administration | Drug therapy | Heart diseases | Risk factors | Saxagliptin | Myocardial infarction | Cerebral infarction | Heart attacks | Peptidase | Diabetes mellitus | Pancreatitis | Cardiovascular disease | Angina | Patients | Heart rate | Ischemia | Diabetes | Cardiovascular diseases | Diabetes mellitus (non-insulin dependent)
Journal Article